Oral lactoferrin as a treatment of pediatrics’ anemia resulted from chronic kidney diseases: a randomized controlled trial
Abstract Anemia in pediatrics is often associated with chronic conditions such as chronic kidney disease (CKD). It can worsen the disease prognosis and affect quality of life. Injectable dosage forms are predominantly used in its treatment with various side effects. This randomized and parallel clin...
Saved in:
Main Authors: | Sahar Kamal Hegazy, Mai Salah El-Din Koura, Mohamed Shokry Elharoun |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88506-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficulties of iron-deficiency anemia diagnostics
by: I. V. Mayev, et al.
Published: (2014-09-01) -
Heme-Iron OptiFer® in the Treatment of Iron Deficiency Anemia During Pregnancy
by: Ibrahim A. Abdelazim, et al.
Published: (2022-03-01) -
Serum hepcidin level with iron profile assay might replace bone marrow iron study as a diagnostic tool for evaluation of anemia in elderly without chronic renal disease
by: Sukdev Manna, et al.
Published: (2025-01-01) -
Lactoferrin alleviates the adverse effects of early-life inflammation on depression in adults by regulating the activation of microglia
by: Wenli Wang, et al.
Published: (2025-02-01) -
Gestational Diabetes Mellitus and Iron Deficiency Anemia
by: Neslihan Yerebasmaz, et al.
Published: (2015-12-01)